Detalhe da pesquisa
1.
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer.
Cancer Immunol Immunother
; 72(3): 759-767, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976415
2.
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer.
Nat Commun
; 15(1): 1349, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355607
3.
Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries-Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients.
Cancers (Basel)
; 15(17)2023 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37686626
4.
Anti-PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8+ T cells.
Clin Cancer Res
; 28(1): 215-226, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34615720
5.
Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients.
Front Immunol
; 13: 898498, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36091056
6.
CD45RA+CCR7- CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab.
J Immunother Cancer
; 7(1): 149, 2019 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31176366